The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype
Free accessResearch articleFirst published online June, 2007
The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype
The present study investigated genetic variation in the 3’ flanking region of ApoA-I (PstI), the 3’ untranslated region of ApoC-III (SstI) and intron 2 of ApoA-IV (XbaI) in 435 type 2 diabetes mellitus patients, divided according to the presence or absence of coronary heart disease (CHD). Uncommon allele frequencies (P2, S2, X2) were 17.5%, 32.5%, 16.2% and 29.5%, 17.9%, 13.8% in patients with and without CHD, respectively. Linkage disequilibrium (D’ = 0.31-0.73, p<0.01) was observed in all diallelic pairs except XbaI/PstI and XbaI/SstI in patients having CHD. Haplotype analysis revealed that P1-S2-X1 is a susceptibility haplotype that increases the risk of CHD in diabetes (OR 2.85, CI 1.51-5.61), exacerbating risk (OR 3.57, CI 1.81-7.45) even after adjustment for confounders.
The findings in the present study suggest that each unit of P1-S2-X1 in diabetes increases the risk of CHD by a factor of 1.37+0.307 (β ± SE), which is manifest in its multiplicative mode.
1. Ford ES, Stefano F.Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up study. Am J Epidemiol1991;133:1220–30.
2.
2. Bierman EL.Atherogenesis in diabetes. Atherosclerosis Thromb1991;12:647–50.
3.
3. Stern MP.Do non-insulin dependent diabetes mellitus and cardiovascular disease share common antecedents?Ann Int Med1996;124:110–16.
4.
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondia-betic subjects with and without prior myocardial infarction. N Engl J Med1998;339:229–34.
5.
5. Trembath RC, Thomas DJ, Hendra TJ, Yudkin JS, Galton DJ.Deoxyribonucleic acid polymorphism of the apoprotein AI-CIII-AIV gene cluster and coronary heart disease in non-insulin-dependent diabetes. Br Med J1987;294:1577–88.
6.
6. Rigoli L, Cucinotta D, Cocozza S. et al. A genetic polymorphism of the apolipoprotein AI-CIII gene cluster is associated with coronary heart disease in non insulin dependent diabetes mellitus. Diabetes Nutr Metab1994;7:71–5.
7.
7. Rigoli L, Raimondo G, Di Benedetto A et al. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus. Acta Diabetol1995;4:251–6.
8.
8. Karathanasis SK, McPheroson J, Zannis VI, Breslow JL.Linkage of human Apolipoprotein AI, CIII and AIV genes. Nature1983;304:371–3.
9.
9. Groenendijk M, Cantor RM, de Bruin TW, Dallinga-Thie GM.The ApoAI-CIII-AIV gene cluster. Atherosclerosis2001;157:1–11.
10.
10. Mooradian AD, Haas MJ, Wong NC.Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes2004;53:513–20.
11.
11. Gao J, Wei Y, Huang Y. et al. The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice. J Biol Chem2005;13:12559–66.
12.
12. Ordovas JM, Civeira F, Genest J Jr et al. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis1991;87:75–86.
13.
13. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE.Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis1993;100:157–69.
14.
14. Paul-Hayase H, Rosseneu M, Robinson D, Van Bervliet JP, Deslypere JP, Humphries SE.Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet1992;88:439–46.
15.
15. Kee F, Amouyel P, Fumeron F.Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis1999;145:187–95.
16.
16. Vavatsi NA, Kouidou SA, Geleris PN.Increased frequency of the rare PstI allele (P2) in a population of CAD patients in northern Greece. Clin Genet1995;47:22–6.
17.
17. Alberti KG, Zimmet PZ.Definition, diagnosis and classification of Diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med1998;15:539–53.
18.
18. Haviland MB, Kessling AM, Davignon J, Singh CF.Estimation of Hardy-Weinberg and pairwise disequilibrium in the apolipoprotein AI-CIII-AIV gene cluster. Am J Hum Genet1991;49:350–65.
19.
19. Epstein MP, Satten GA.Inference on haplotype effects in case-control studies using unphased genotype data. Am J Hum Genet2003;73:1316–29.
20.
20. Akaike H.Factor analysis and AIC. Psychometrika1987;52:317–32.
21.
21. Excoffier L, Laval G, Schneider S.Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online2005;1:47–50.
22.
22. Botstein D, White RL, Skolnick M, Davis RW.Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet1980;32:314–31.
23.
23. Russo GT, Meigs JB, Cupples LA. et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis2001;158:173–81.
24.
24. Rodrigo E, Gonzalez-Lamuno D, Ruiz JC.Apolipoprotein C-III and E polymorphisms and cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation. Am J Transplant2002;2:343–8.
25.
25. Wile DB, Barbir M, Gallagher J.Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration. Atherosclerosis1989;78:9–18.
26.
26. Paulweber B, Friedl W, Krempler F, Humphries SE, Sandhofer F.Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis1988;73:125–33.
27.
27. Simons LA, Balasubramaniam S, Szanto A. et al. High density lipoproteins, genetic polymorphism for apoA-I and coronary artery disease. Aus N Z J Med1991;21:330–4.
